Orgenesis (FRA:45O) Days Inventory : 6.24 (As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Orgenesis Days Inventory?

Days Inventory is also known as Days Sales of Inventory (DSI). Orgenesis's Average Total Inventories for the three months ended in Mar. 2024 was €0.03 Mil. Orgenesis's Cost of Goods Sold for the three months ended in Mar. 2024 was €0.45 Mil. Hence, Orgenesis's Days Inventory for the three months ended in Mar. 2024 was 6.24.

The historical rank and industry rank for Orgenesis's Days Inventory or its related term are showing as below:

FRA:45O' s Days Inventory Range Over the Past 10 Years
Min: 1.88 Med: 16.71 Max: 41.49
Current: 4.79

During the past 13 years, Orgenesis's highest Days Inventory was 41.49. The lowest was 1.88. And the median was 16.71.

FRA:45O's Days Inventory is ranked better than
98.47% of 654 companies
in the Biotechnology industry
Industry Median: 192.63 vs FRA:45O: 4.79

Orgenesis's Days Inventory increased from Mar. 2023 (4.18) to Mar. 2024 (6.24). It might indicate that Orgenesis's sales slowed down.

Inventory Turnover measures how fast the company turns over its inventory within a year. Orgenesis's Inventory Turnover for the three months ended in Mar. 2024 was 14.61.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Orgenesis's Inventory-to-Revenue for the three months ended in Mar. 2024 was 0.24.

Orgenesis Days Inventory Historical Data

The historical data trend for Orgenesis's Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Orgenesis Days Inventory Chart

Orgenesis Annual Data

Trend

Nov14

Nov15

Nov16

Nov17

Nov18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Inventory

Get a 7-Day Free Trial

25.86

1.96

1.83

8.17

4.58

Orgenesis Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Days Inventory	Get a 7-Day Free Trial															4.18	2.31	22.11	19.42	6.24

Competitive Comparison of Orgenesis's Days Inventory

For the Biotechnology subindustry, Orgenesis's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Orgenesis's Days Inventory Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Orgenesis's Days Inventory distribution charts can be found below:

* The bar in red indicates where Orgenesis's Days Inventory falls into.

Orgenesis Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Orgenesis's Days Inventory for the fiscal year that ended in Dec. 2023 is calculated as

	Days Inventory (A: Dec. 2023 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (A: Dec. 2022 )	+	Total Inventories (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (0.113	+	0.031)	/	2 )	/	5.736	*	365
=	0.072					/	5.736	*	365
=	4.58

Orgenesis's Days Inventory for the quarter that ended in Mar. 2024 is calculated as:

	Days Inventory (Q: Mar. 2024 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (Q: Dec. 2023 )	+	Total Inventories (Q: Mar. 2024 ))	/	count )	/	Cost of Goods Sold (Q: Mar. 2024 )	*	Days in Period
=	( (0.031	+	0.031)	/	2 )	/	0.453	*	365 / 4
=	0.031					/	0.453	*	365 / 4
=	6.24

Orgenesis (FRA:45O) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

Orgenesis's Inventory Turnover for the three months ended in Mar. 2024 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	0.453	/	0.031
	=	14.61

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Orgenesis's Inventory to Revenue for the three months ended in Mar. 2024 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	0.031	/	0.13
	=	0.24

Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.

Orgenesis Days Inventory Related Terms

Thank you for viewing the detailed overview of Orgenesis's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Orgenesis (FRA:45O) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Orgenesis Inc (FRA:45O) » Definitions » Days Inventory

Comparable Companies

Traded in Other Exchanges

ORGS:USA

Address

20271 Goldenrod Lane, Germantown, MD, USA, 20876

Website

https://www.orgenesis.com

Orgenesis Inc is a biotech company working to unlock the potential of cell and gene therapies. It is focused on autologous therapies, with processes and systems that are developed for each therapy using a closed and automated processing system approach that is validated for compliant production near the patient for treatment of the patient at the point of care (POCare). The Company's business includes two reporting segments: Morgenesis and Therapies.

Orgenesis (FRA:45O) Headlines

No Headlines